Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T4QX
|
||||
Former ID |
DIB012912
|
||||
Drug Name |
CTEP
|
||||
Synonyms |
MGluR5 antagonist (oral), Roche; Metabotropic glutamate receptor 5 antagonist (oral), Roche
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Fragile X syndrome [ICD9: 332, 759.83; ICD10:F02.3, G20, Q99.2] | Investigative | [541547] | ||
Company |
F Hoffmann-La Roche Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H13ClF3N3O
|
||||
InChI |
InChI=1S/C19H13ClF3N3O/c1-12-17(8-3-14-9-10-24-18(20)11-14)25-13(2)26(12)15-4-6-16(7-5-15)27-19(21,22)23/h4-7,9-11H,1-2H3
|
||||
InChIKey |
GOHCTCOGYKAJLZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor 5 | Target Info | Antagonist | [543750] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.